×

Compositions comprising azelastine

DC
  • US 9,919,050 B2
  • Filed: 08/23/2013
  • Issued: 03/20/2018
  • Est. Priority Date: 11/24/2004
  • Status: Active Grant
First Claim
Patent Images

1. A liquid intranasal composition, comprising:

  • about 0.01% 0.05% to about 0.5% (w/v) azelastine hydrochloride;

    about 0.01% 0.1% to about 0.5% (w/v) sucralose; and

    about 0.1% to about 10% (w/v) sorbitol.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×